Evidence map›Paper›PMID 35626094›Full record

ArticleCancers2022

Three-Dimensional Organotypic Cultures Reshape the microRNAs Transcriptional Program in Breast Cancer Cells.

Yarely M Salinas-Vera, Jesús Valdés, Alfredo Hidalgo-Miranda, Mireya Cisneros-Villanueva, Laurence A Marchat, Stephanie I Nuñez-Olvera, Rosalio Ramos-Payán, Carlos Pérez-Plasencia, Lourdes A Arriaga-Pizano, Jessica L Prieto-Chávez and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Yarely M Salinas-VeraDepartamento de Bioquímica, CINVESTAV-IPN, Ciudad de México 07360, Mexico.
Jesús ValdésDepartamento de Bioquímica, CINVESTAV-IPN, Ciudad de México 07360, Mexico.ORCID 0000-0003-1787-9229
Alfredo Hidalgo-MirandaLaboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Ciudad de México 14610, Mexico.ORCID 0000-0003-2315-3977
Mireya Cisneros-VillanuevaLaboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Ciudad de México 14610, Mexico.ORCID 0000-0002-5662-0247
Laurence A MarchatPrograma en Biomedicina Molecular y Red de Biotecnología, Instituto Politécnico Nacional, Ciudad de México 07320, Mexico.
Stephanie I Nuñez-OlveraDepartamento de Biología Celular y Fisiología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.
Rosalio Ramos-PayánFacultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa, Culiacán 80030, Mexico.ORCID 0000-0001-7500-7571
Carlos Pérez-PlasenciaLaboratorio de Genómica, Instituto Nacional de Cancerología, Ciudad de México 14080, Mexico.
Lourdes A Arriaga-PizanoUnidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades del Centro Medico Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.
Jessica L Prieto-ChávezLaboratorio de Citometria de Flujo, Centro de Instrumentos, Coordinación de Investigación en Salud, Hospital de Especialidades del Centro Médico Siglo XXI, Instituto Mexicano del Seguro Social, Ciudad de México 06720, Mexico.ORCID 0000-0002-0720-4271
César López-CamarilloPosgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, Ciudad de México 03100, Mexico.ORCID 0000-0002-9417-2609
Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional · MXMexican Social Security Institute · MXNational Institute of Genomic Medicine · MXInstituto Nacional de Cancerología · MXInstituto Politécnico Nacional · MXUniversidad Autónoma de la Ciudad de México · MXUniversidad Autónoma de Sinaloa · MXUniversidad Nacional Autónoma de México · MX

Funding

Consejo Nacional de Ciencia y Tecnología FORDECYT-PRONACES/51207/2020
6 · The paper itself

Abstract

The 3D organotypic cultures, which depend on the growth of cells over the extracellular matrix (ECM) used as a scaffold, can better mimic several characteristics of solid cancers that influence tumor biology and the response to drug therapies. Most of our current knowledge on cancer is derived from studies in 2D cultures, which lack the ECM-mediated microenvironment. Moreover, the role of miRNAs that is critical for fine-tuning of gene expression is poorly understood in 3D cultures. The aim of this study was to compare the miRNA expression profiles of breast cancer cells grown in 2D and 3D conditions. On an on-top 3D cell culture model using a basement membrane matrix enriched with laminin, collagen IV, entactin, and heparin-sulfate proteoglycans, the basal B (Hs578T) and luminal (T47D) breast cancer cells formed 3D spheroid-like stellate and rounded mass structures, respectively. Morphological changes in 3D cultures were observed as cell stretching, cell-cell, and cell-ECM interactions associated with a loss of polarity and reorganization on bulk structures. Interestingly, we found prolongations of the cytoplasmic membrane of Hs578T cells similar to tunneled nanotubes contacting between neighboring cells, suggesting the existence of cellular intercommunication processes and the possibility of fusion between spheroids. Expression profiling data revealed that 354 miRNAs were differentially expressed in 3D relative to 2D cultures in Hs578T cells. Downregulated miRNAs may contribute to a positive regulation of genes involved in hypoxia, catabolic processes, and focal adhesion, whereas overexpressed miRNAs modulate genes involved in negative regulation of the cell cycle. Target genes of the top ten modulated miRNAs were selected to construct miRNA/mRNA coregulation networks. Around 502 interactions were identified for downregulated miRNAs, including miR-935/

Indexed as

3D culturesbreast cancermicroRNAsmiRNA/mRNA coregulation networks

Identifiers

PMID35626094
PMCPMC9139376
OpenAlexW4280492311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.